CliffBio
small molecule

ESIMIL

GUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameESIMIL
Active ingredientGUANETHIDINE MONOSULFATE; HYDROCHLOROTHIAZIDE
Strength10MG;25MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.